What is Regenxbio's financing cash flow?

Regenxbio (RGNX) reported financing cash flow of -$13.64M in Q1 2026.

How has Regenxbio's financing cash flow changed year-over-year?

Regenxbio's financing cash flow decreased by 135.4% year-over-year, from -$5.79M to -$13.64M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Regenxbio RGNX Financing Cash Flow

Financing Cash Flow at other companies

Regeneron PharmaceuticalsREGN

-$802.2M+26.3%

Sarepta Therapeutics, Inc.SRPT

$241K-98.1%

BiogenBIIB

-$43.8M-90.4%

BioMarin PharmaceuticalsBMRN

$813.17M+2,197%

EyePoint, Inc. EYPT

-$2.61M-175%

4D Molecular TherapeuticsFDMT

$11.48M—

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's financing cash flow?: Regenxbio (RGNX) reported financing cash flow of -$13.64M in Q1 2026.
How has Regenxbio's financing cash flow changed year-over-year?: Regenxbio's financing cash flow decreased by 135.4% year-over-year, from -$5.79M to -$13.64M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.